Skip to main content

Tag: united states

Comparing U.S. And European Cannabis Legalization

Starting in 2012 with Colorado and Washington State, jurisdictions in the U.S. began to modernize their cannabis policies to permit adult-use cannabis activity. In some cases, the reform efforts involved legalizing sales of recreational cannabis products. Today, two dozen states in the U.S. have adopted adult-use legalization, as well as Washington D.C.

In recent years, adult-use cannabis policy modernization has spread to the European continent. The first European nation to adopt a national recreational cannabis law was Malta in 2021, followed by Luxembourg in 2023 and Germany in 2024.

Earlier this year, lawmakers in the Czech Republic also adopted a national adult-use cannabis legalization measure, with the new law set to take effect on January 1st, 2026. A national adult-use cannabis legalization measure was recently introduced in Slovenia, and policymakers in Switzerland are also considering a national recreational legalization measure.

At the state level in the U.S., and the national level in Europe, no two legal jurisdictions have the same model. Every jurisdiction permits differing cultivation, possession, and commerce policies and regulations to some degree.

In the U.S., most legal cannabis states permit home cultivation, but not all of them. Washington State is a noteworthy example. Despite being one of the first legal states in the U.S., along with Colorado, Washington still prohibits adult-use home cannabis cultivation. Illinois also does not permit adult-use cultivation.

Additionally, most legal recreational jurisdictions in the U.S. permit adult-use cannabis product sales, but there are exceptions. Virginia allows legal adult-use cannabis possession, but not sales. Washington D.C. also permits personal adult-use activity, but not adult-use product sales.

Vermont was the first state in the U.S. to legalize via legislative action, and initially did not permit adult-use cannabis sales, but later modernized its adult-use model to permit sales. All the while, cannabis has remained a Schedule I substance at the federal level in the United States, and all adult-use activity is prohibited at the federal level, but ‘tolerated’ at the state and district levels.

A somewhat similar public policy scenario exists in Europe, where European Union agreements largely prohibit modernized adult-use cannabis policies and regulations, but do allow limited national-level legalization to proceed in some ways.

Current European Union agreements prohibit national adult-use product sales, like what is occurring in Canada and Uruguay, but do allow reform measures to be adopted by its member nations if they fall within research and ‘boosting public health outcome’ parameters.

Home cultivation is so far a standard component of adult-use legalization models in Europe. Malta, Luxembourg, and Germany all permit home cultivation by adults, and once Czechia’s legalization law takes effect, it will also allow home cultivation.

Limited adult-use commerce of non-cannabis light products occurs legally via two channels in Europe right now. The first is via cultivation associations, in which consumers become members of an association and source their cannabis products. Malta and Germany permit cultivation associations, but Luxembourg does not, and when Czechia’s law takes effect, it will also continue to prohibit cultivation associations.

The other EU-approved legal channel for recreational cannabis commerce is regional adult-use cannabis pilot trials. Pilot trials are already operating in the Netherlands and Switzerland, even though both nations have yet to adopt national legalization measures, and pilots are expected to launch someday in Germany too. The legalization models in Malta, Luxembourg, and Czechia do not include pilot trials.

One of the biggest differences between the United States and Europe’s adult-use policy modernization efforts is the way that they are described. Europe’s recent policy modernization models are often described as ‘decriminalization’ even though they would constitute ‘legalization’ in the United States.

The difference between how the two are described is often in the eye of the beholder. Many cannabis policy reformists in the United States do not consider policies to be true legalization unless they involve permitted home cultivation. Conversely, many advocates in Europe do not consider policies to be true legalization unless national adult-use sales are permitted.

My home state, Oregon, became the first state in the U.S. to adopt a cannabis decriminalization measure in 1973, removing the criminal charge associated with possessing a personal amount of cannabis and replacing the penalty with a fine.

Later, in 2014, voters in Oregon approved a measure that removed the fine and allowed adults to possess a personal amount of cannabis with no penalty at all. In my personal opinion, that is the difference between decriminalization and legalization, but I also respect the opinions of other longtime cannabis activists who feel differently.

I am hopeful that in the not-too-distant future, lawmakers on both sides of the Atlantic Ocean will adopt sensible, harmonized cannabis policies and regulations so that consumers and patients are protected, and the industry can reach its full potential.

A Big Win For Hemp In The United States

Consumable hemp products containing tetrahydrocannabinol (THC) have increased exponentially in availability and popularity in the United States after the adoption of the 2018 Farm Bill, which legalized hemp production nationwide in the U.S.

Unfortunately, a byproduct of the rise of intoxicating hemp products in the U.S. is political and regulatory turmoil as states have scrambled to regulate the products, and in some cases, shut down the sector entirely. Arguably, ground zero for the ongoing hemp THC product battle in the U.S. is Texas.

Lawmakers in Texas introduced and approved Senate Bill 3, which would have banned hemp-derived THC products and related activity in Texas. The measure was one signature away from becoming law. However, at the last minute, the legislation was vetoed by Texas Governor Greg Abbott.

“Texas Gov. Greg Abbott vetoed a bill Sunday to ban all THC consumables, allowing the booming market flush with THC-infused vapes, gummies and other products to continue to be sold across the state.” reported the Associated Press. “Abbott, a Republican, waited until the final moment to veto the bill in what would have been one of the most restrictive THC bans in the country and a significant blow to the state’s billion-dollar industry.”

“The law would have made it a misdemeanor to own, manufacture or sell consumable THC, or tetrahydrocannabinol, products and was the latest push by states to regulate THC after a 2018 federal law allowed states to regulate hemp, a similar plant to marijuana that can be synthetically processed to produce THC, the compound giving marijuana its psychoactive properties.” the Associated Press also reported.

“SB 3 would have banned widely used, federally legal hemp-derived products, pushing consumers toward unsafe alternatives and threatening public health and choice. Governor Abbott’s veto protects the hundreds of thousands of farmers, veterans, small businesses and adult consumers across Texas who rely on hemp for wellness and their livelihoods.” stated the Texas Hemp Business Council in a press release.

“Texas already has strong hemp regulations under HB 1325, such as strict rules on THC limits, full panel testing, licensing, labeling and accessible certificates of analysis. We continue to advocate for sensible additions, such as limiting sales to those 21 and older, requiring child-resistant packaging, and establishing setbacks from schools, all of which were rejected by proponents of SB 3 in both the 88th and 89th Legislatures.” the Council also wrote.

“Polling consistently shows that Texans do not support a ban on hemp-derived products. We commend Governor Abbott for his leadership and for listening to the more than 150,000 petition signers and thousands more who shared their stories through handwritten letters. We remain committed to working with lawmakers and stakeholders to support a safe, well-regulated hemp industry, not just for Texas, but as a model for the nation.” the Council concluded.

Between $19.1 and $22.4 billion in economic activity is generated by the Texas hemp-derived cannabinoid retail, manufacturing, and wholesale sectors, according to the Texas Hemp Business Council.

The Global Exchange At MJBizCon – Where Cannabis Business Leaders Connect

The emerging legal cannabis industry is spreading across the globe, with new markets seemingly being launched year after year, and existing markets continuing to expand. There has never been a more exciting time for legal cannabis businesses than right now, and the future of the legal international cannabis industry continues to get brighter as market projections demonstrate.

At the recent International Cannabis Business Conference in Berlin, leading international cannabis industry economist Beau Whitney, founder of Whitney Economicsestimated that the potential global medical and adult-use cannabis market is roughly $237.8 billion. Mr. Whitney estimated that the value of the global industrial hemp industry could be $456.2 billion.

Industry members in the United States and Canada are increasingly looking toward markets on other continents for expansion, and rightfully so. Amazing opportunities, particularly in Europe, are being created as governments modernize their cannabis policies.

It can be daunting for North American industry members to learn about and navigate the shifting legal global cannabis industry landscape, and even harder to effectively network at an international level. With that in mind, interested people and entities should check out The Global Exchange at the upcoming MJBizCon event in Las Vegas, Nevada, in December.

MJBizCon and the International Cannabis Business Conference have partnered to present The Global Exchange — a premier destination for international collaboration. MJBizCon has served as the top cannabis industry event in the Western Hemisphere for several years now, and likewise for the International Cannabis Business Conference in the Eastern Hemisphere. The collaboration between the two events is a must-attend for people serious about succeeding in the international cannabis industry.

New to 2025, The Global Exchange pavilion bridges the North American market with fast-growing global regions, including emerging opportunities in Europe. Get timely insights and unmatched networking directly on the show floor. It is where dealmakers, exporters, and investors can find their next high-value business partnership.

“The partnership between MJBizCon and the International Cannabis Business Conference provides a bridge for U.S. and Canadian operators to explore the idea of expanding operations to other parts of the world and helping international industry members forge relationships with entities in the North America markets.” stated Alex Rogers, CEO and Executive Producer of the International Cannabis Business Conference.

Over 20,000 people are expected to attend MJBizCon in Las Vegas in December, including leading entrepreneurs, investors, policymakers, regulators, and industry service providers. The event will feature over 1,000 exhibitors, over 200 industry speakers, and over 60 conference sessions. People can find out more, including which attendee packages are available, at MJBizConference.com.

Study: Cannabis Legalization Not Associated With Increased Adolescent Use

Modern cannabis prohibition policies were enacted starting in the early 1900s, and since that time, cannabis advocates around the world have worked very hard to reform laws that prohibit cannabis activity, including cannabis commerce.

Leading up to cannabis reform votes and implementation, cannabis opponents often make predictions that such reforms will result in increased cannabis use by adolescents. A team of international researchers based in Australia and the Czech Republic recently conducted a study focusing on the topic of cannabis reform and adolescent usage rates.

The study’s findings were published in the academic publication International Journal of Drug Policy.

“Several jurisdictions have pursued reforms that regulate cannabis production and/or sale for adult (non-medical) use. Looking at outcomes of such reforms across multiple jurisdictions may help to identify outcomes that are inherent to non-criminal cannabis supply, as well as provide insight into the outcomes of specific regulation models.” the researchers wrote about their study.

“We identified nine indicators of cannabis policy outcomes and aggregated them into three domains (social outcomes, outcomes in cannabis use, health-related outcomes). We assessed these outcomes across five jurisdictions with different models of regulating cannabis supply (Netherlands, Spain, U.S. states that legalized cannabis, Uruguay, and Canada).” the researchers wrote about their methodology.

“We used a three-level systematic literature review, prioritising studies with quasi-experimental design (i.e. comparative and longitudinal). We categorised the studies according to their design and the type of outcome (increase, decrease, or no outcome).” they also wrote.

Currently, recreational cannabis sales are limited to adult residents in Uruguay. Canada permits recreational cannabis sales to anyone of legal age. The Netherlands limits legal sales to participants of regional adult-use cannabis commerce pilot trials, fewer than half of the states in the U.S. permit adult-use sales, and sales in Spain operate in a ‘legal grey area.’

“Across long-standing as well as recent cannabis supply regimes, and across different models of cannabis supply, our review identified common outcomes: a decrease in cannabis-related arrests, an increase in adult (but not adolescent) cannabis use, and increase in healthcare utilization (not traffic-related).” the researchers found.

“Regulating cannabis supply may be associated with benefits in the social area and with potential harms regarding public health; there may though be trade-offs depending on the choice of a cannabis regulation model. Jurisdictions may attempt to mix and match the present models of cannabis regulation to achieve the best ratio of benefits and harms.” the study’s authors concluded.

Cannabis is also legal for adult use at a national level in Malta, Luxembourg, Germany, and South Africa. However, of those countries, only Malta and Germany currently provide legal channels for acquiring recreational cannabis beyond home cultivation. Both Malta and Germany are home to legal member-based cultivation associations. Adult-use cannabis legalization is also expected to be implemented soon in the Czech Republic.

Switzerland is another jurisdiction where regional adult-use cannabis commerce pilot trials are operating. The largest regional adult-use cannabis pilot trial in Switzerland is operating in Zurich, where a total of 4,400 people between the ages of 18 and 80 are participating.

“Over 90 percent of participants now obtain their cannabis products from legal sources, i.e. from one of the three specialist stores or one of the nine pharmacies taking part.” Blue News reported about Zurich’s pilot trial.

Another jurisdiction in Switzerland participating in regional adult-use cannabis commerce pilot trials is Basel. The results of a previous study, which was the first academic reporting of its kind, were published on the University of Basel’s website in addition to being published in the academic journal Addiction.

“Public health-oriented recreational cannabis access may decrease cannabis use and cannabis-related harms, especially among those using other drugs.” the researchers of that study concluded.

“Furthermore, the study was able to dispel fears that legalization could exacerbate the psychopathological symptoms associated with cannabis consumption in addition to consumption itself: after the first six months, there was no difference between the two study groups in terms of depression, anxiety or other symptoms.” stated the University of Basel on its website.

“The interim assessment after two years of study shows a significant improvement in the mental state of the approximately 300 or so participants who are still taking part.” the University also wrote.

Earlier this year, Marijuana Moment reported that a government-commissioned report found that  Switzerland’s adult-use cannabis legalization pilot program is “running smoothly,” with “no indication of any disturbances to public order.”

“About two years after the pilot program launched in seven municipalities across the country, the Federal Office of Public Health (FOPH) study—carried out by the University of Lausanne and the University of Applied Sciences Northwestern Switzerland—generally determined that the initiative has been a success.” the outlet also reported.

Previously published government data from the United States found that in jurisdictions where adult-use cannabis legalization was adopted, consumption rates among minors had reduced post-legalization compared to pre-legalization. The results of a Canadian study that was published earlier this year found that while reported overall cannabis use in Canadian society increased post-legalization, “misuse decreased.”

U.S. Cannabis Industry Capital Is Tighter, But Still Flowing

The emerging legal cannabis industry in the United States continues to mature and evolve, and that is particularly evident when it comes to businesses raising capital. Investors are being more strategic than ever when it comes to funding cannabis companies in the U.S., and that, in turn, is resulting in industry operators having to update their approaches and strategies.

Fortunately, cannabis industry capital is still flowing in the U.S., albeit in a more competitive environment. It is more important than ever for cannabis startups and established companies to perform adequate due diligence, craft pitches that resonate with investors, and network effectively.

Attending worthwhile conferences is a must these days, and the upcoming Benzinga Cannabis Capital Conference is a great opportunity for members of the United States cannabis space. The event is taking place on June 8th-10th, 2025, in Chicago, Illinois, at the Marriott Magnificent Mile. Top industry leaders, entrepreneurs, and investors will gather to learn about the new fundraising landscape, build meaningful industry relationships, and ultimately get deals done.

The United States cannabis industry is continuing to increase in size and potential. Leading international cannabis economist Beau Whitney, founder of Whitney Economics, estimates that legal cannabis sales in the U.S. topped $30 billion in 2024. That figure does not include sales involving hemp-derived cannabinoids. Whitney projects that legal sales will top $34 billion in 2025, a roughly 13.1% increase compared to 2024.

“Even in today’s environment, capital is getting deployed. It’s just happening differently,” says Javier Hasse, strategic advisor at Benzinga. “Founders are pivoting, investors are more strategic, and new deal structures are emerging. This year’s conference will bring those conversations to the forefront and help the entire ecosystem adjust and thrive.”

The Benzinga Cannabis Capital Conference will feature:

  • 2,000+ attendees
  • 120+ speakers across business, investment, branding, and policy
  • 3,000+ meetings booked in advance
  • 40+ curated networking tables
  • A buzzing 7th-floor exhibit hall where deals and conversations happen nonstop
  • Hundreds of investors in the room, from early-stage VCs to institutional firms

The event is packed with expert speakers and presenters, including (but not limited to):

  • Kim Rivers (Trulieve)
  • George Archos & Aaron Miles (Summer)
  • Charlie Bachtell (Cresco Labs)
  • Beena Goldenberg (Organigram Global)
  • Vic Mensa (93 Boyz)
  • Matt Hawkins (Entourage Effect Capital)
  • Christelle Gedeon (Canopy Growth)
  • Kristi Palmer (Kiva Confections)
  • Tim Seymour (CNBC / Seymour Asset Management)
  • Cameron Forni (Adaptaphoria)
  • Paul Weaver (Boston Beer Co. – TeaPot)
  • Dan Ahrens (AdvisorShares)
  • Brady Cobb (Sunburn Cannabis)
  • Dr. Chanda Macias (Women Grow)
  • Ricardo Baca (Grasslands)
  • Rachelle Gordon (GreenState)
  • Rachel Wright, CPA (Verdant Strategies / 420 CPA)
  • Leah Heise, Irina Dashevsky, Gary Santo, Samantha Gleit, Cy Scott, and many more

To enhance the conference experience and help effectively map out their plans, a new conference app was launched. It includes the following features, which are built for business:

  • Access and message the full attendee list
  • Book meetings directly
  • Build custom schedules
  • Receive real-time updates
  • Enter raffles for prizes (winners announced at the closing party)

Through partnerships with organizations like Women Grow and BIPOCann, Benzinga provides earned opportunities for women and minority-owned cannabis businesses to access stage time, exhibit space, and investor connections.

“Benzinga has opened the doors of access for our community, and we are ready to drive innovation and growth.” stated Dr. Chanda Macias, CEO of Women Grow.

The conference will also involve a closing night afterparty titled ‘The Final Spark’ on June 10th from 9 pm to after midnight. The afterparty, to be held at the Tunnel Treehouse Rooftop and hosted by Dickinson Write, gives attendees one last chance to close deals with a skyline view of Chicago.

To find out more about the conference and to book your tickets before the event sells out, go to: www.benzinga.com/cannabis-conference

Cannabis And Hemp Tourism Is A Growth Engine

The concept of people traveling to faraway destinations to enjoy consuming food and wine is not a new thing. Television shows are dedicated to the activity, and massive subsectors of the tourism industry are built around the concept. The same is proving to be true for cannabis and hemp tourism at an increasing rate.

A multi-year survey conducted by MMGY Travel Intelligence discovered that the cannabis travel audience in the United States alone includes roughly 72 million Americans, or 37% of the active leisure travel audience in the United States.

“Half of these interested travelers would consider visiting a cannabis shop, and a quarter of them are not regular cannabis users but are open to such experiences while traveling.” reported Travel Age West about the survey results.

In 2023, inbound tourism spending in Europe was an estimated 645 billion euros. At the intersection of these industries – cannabis, hemp, and travel – are opportunities for growth and creative differentiation.

Medical tourism, leisure travel, events, and business travel, including group meetings and conferences, are all part of it. Cannabis travel expert Brian Applegarth of Applegarth Strategies recently moderated a panel dedicated to cannabis and hemp tourism at the International Cannabis Business Conference in Berlin. Mr. Applegarth was joined by:

  • Mara Gordon – Co-Founder, Aunt Zelda’s, Octopi Wellness, Zelira Therapeutics
  • Jim Zielinski – General Manager, The Bulldog Hotel
  • Cristina Sánchez – Full Professor of Biochemistry and Molecular Biology at Complutense University
  • Ivan Ross Vrána – Managing Partner, Diplomat Consulting
  • Teddy Cabugos – President, Director, Sunstone Winery

Click here to watch a video of the ninety-minute presentation and panel discussion unpacking the tourism opportunities for cannabis and hemp businesses and brands in the European market.

Why U.S. MSOs Are Looking To Invest In Germany And Europe

For many years, the emerging legal cannabis industry in the United States has operated in siloed markets, with each jurisdiction having its own laws and regulations. While that is still largely the case from a public policy standpoint, in recent years, larger cannabis companies in the U.S. have expanded to multiple state-level markets.

Multistate operators (MSOs), as they are known, are gaining a larger market share of the cannabis industry in the U.S., with Cresco Labs being one of the most prominent and successful MSOs. Led by CEO Charlie Bachtell, Cresco Labs is a publicly traded, vertically integrated MSO that produces the U.S. industry’s #1 portfolio of cannabis brands. The company also operates licensed dispensaries under the Sunnyside brand.

Mr. Bachtell was named one of Chicago’s most visionary and accomplished business leaders in the Chicago Titan 100 Awards and received the Captains of the Industry Award from the American Trade Association for Cannabis Hemp. Through his leadership of Cresco Labs, the company has been recognized as a Best-Led American Company by Inc. Magazine. Currently, Mr. Bachtell is the Chairman of the National Cannabis Roundtable and is also an adjunct professor at Northwestern University’s Pritzker School of Law, teaching a course on legal and regulatory issues in the cannabis industry.

Charlie Bachtell provided the keynote address at the recent International Cannabis Business Conference in Berlin, focusing on the topic of why U.S. MSOs are looking to invest in Germany and Europe. The cannabis industry is going global, and multistate operators in the U.S. are increasingly identifying expansion opportunities in Europe. Click on this link to see a video of Mr. Batchtell’s insightful presentation via the International Cannabis Business Conference’s YouTube channel.

MJBizCon Comes Back To Las Vegas On December 3-6

MJBizCon, the top cannabis industry event in the United States, is coming back to Las Vegas next week on December 3rd-6th, 2024. The event, which is often described as ‘the Super Bowl of Cannabis’ is a must-attend for anyone serious about succeeding in the emerging legal U.S. industry.

Many members of the United States cannabis industry measure their calendar years from MJBizCon to MJBizCon, and rightfully so. In many ways, the event serves as a U.S. cannabis industry family reunion, with people from all over the country converging at MJBizCon to see their friends and colleagues and forge new relationships and partnerships.

Next week’s event is the thirteenth installment of the conference and will be bigger and better than ever. I was personally in attendance at the first-ever MJBizCon back in 2012, with the inaugural MJBizCon being held in Denver, Colorado the day after the state’s voters approved the nation’s first adult-use legalization measure.

I had attended other cannabis events over the years up to that point, but it was readily apparent that something special was beginning at the first MJBizCon event. Since that time, the legal industry in the United States has exploded, experiencing exponential growth across the country and the rise of the legal industry in the U.S. was paralleled by the rise of the now iconic MJBizCon.

79% of people living in the United States now live in a county with at least one regulated cannabis dispensary according to an analysis by the Pew Research Center. The Pew Research Center also found the following:

  • 74% of people in the U.S. live in a state where recreational or medical cannabis is legal
  • There are nearly 15,000 cannabis dispensaries in the U.S.
  • California has the most overall dispensaries (3,659)
  • Oklahoma has the most dispensaries per capita (36 dispensaries for every 100,000 residents)

MJBizCon has experienced such tremendous growth over the years, going from hundreds of attendees back in 2012 to tens of thousands in recent years, that the event has long since moved to its current home in Las Vegas, Nevada to accommodate the growing number of attendees and exhibitors. This year’s MJBizCon will feature (including but limited to):

  • Pre-show forums focused on finance and marketing, science and psychedelics, and women’s leadership
  • Expo Hall featuring cultivation products and services, processing, packaging and lab services, retail, and other B2B services
  • 3 full days of informative conference education sessions
  • Over 60 popular networking event opportunities

MJBizCon 2024 is expected to host over 30,000 cannabis entrepreneurs, over 1,400 exhibitors, and over 200 industry speakers.

Members of the International Cannabis Business Conference’s team will be in attendance, and we are encouraging all of our followers in the United States to consider attending MJBizCon 2024 in Las Vegas next week from December 3rd to 6th. You can purchase your tickets at this link here, and make sure to use the special promo code ‘MIPMXAB87’ to receive a special 10% discount!

The emerging legal cannabis industry in the United States is projected to add roughly $112 billion to the nation’s economy in 2024 according to an analysis by MJBiz Daily. The projection is part of the company’s 2024 MJBiz Factbook.

Study Demonstrates Why Banks Are One Of The Biggest Winners Of Legalization

The banking industry and the cannabis industry have a complicated relationship due to prohibition laws. Cannabis businesses have more options for financial services than they have in the past, however, many members of the global cannabis industry still rely on cash-only models and/or struggle to find loans to scale their businesses.

Cannabis businesses are not the only ones harmed by the lack of banking access for the emerging legal cannabis industry. A recent analysis by Whitney Economics (WE), CTrust, and Green Check demonstrates how much profit potential banks are missing out on by not working properly with cannabis businesses.

“A first-of-its-kind report released today projects that the U.S. cannabis industry will need between $65.6B and $130.7B in sustainable growth capital to support new cannabis businesses and help refinance existing ones over the next decade, generating approximately $1.0 billion to $2.4 billion in potential interest revenue for financial institutions willing to lend to cannabis businesses.” stated the authors of the report.

While the financial analysis report is focused on the United States, many of the same findings can be adapted and applied to every other jurisdiction on earth that still hinders or outright prohibits accredited banks from working with the cannabis industry.

“The report also shows that U.S. cannabis retail sales are forecasted to grow from $28.8 billion in 2023 to $87.0 billion by 2035. To support that growth, the U.S. cannabis industry could add 25,000 to 30,000 licenses to roughly 40,000 current licensees—a near doubling of potential lending and interest revenue opportunities for banks.” the authors also stated about their report.

“The funding needed to realize this growth cannot be supported solely by friends and families,” said Beau Whitney, WE founder and chief economist. “By demonstrating regional opportunities and broader market potential, the report aims to empower financial institution lending departments to help educate their boards on risks, rewards and opportunities—all in the hopes of accelerating the industry’s growth by encouraging more financial institutions to participate”

“Banks have long been cautious about entering the cannabis industry due to regulatory and financial risks, though when they do, they have to rely on non-cannabis specific underwriting and due diligence,” said Dotan Y. Melech, CEO and co-founder of CTrust. “This report should pave the way for conversations with financial institutions to develop more informed lending partnerships with the cannabis industry.”

Legal cannabis companies should be afforded the same access to the world’s financial systems that other large legal industries are afforded. As more countries get on the right side of history and modernize their cannabis policies, momentum will continue to build and hopefully comprehensive global reform will be achieved soon.